Literature DB >> 10996914

[Olfactory testing with "sniffin' sticks" for clinical diagnosis of Parkinson disease].

R F Daum1, B Sekinger, G Kobal, C J Lang.   

Abstract

Olfactory dysfunction seems to be one of the most frequent symptoms in idiopathic parkinsonian syndrome (IPS). In contrast to the increasing number of studies providing evidence of the usefulness of olfactory tests in the diagnosis of IPS, clinical assessment of olfactory function is rarely performed. This may be due to the lack of an easy-to-use, inexpensive, standardized, and reliable test. In this study, we administered the newly developed "sniffin' sticks" test to a group of 40 nondemented IPS patients and compared the results with 40 healthy controls matched for age, gender, and smoking habits. In all three subtests including odor identification, odor detection threshold, and odor discrimination, the control group scored significantly better than the IPS group, yielding a specificity and sensitivity of 90% each. Our results indicate that olfactory disturbances in IPS can be found at early stages of the disease, appear bilaterally, and do not correlate with the dominant side of parkinsonism. Therefore, we emphasize that olfactory testing may be a useful tool in the diagnosis of IPS.

Entities:  

Mesh:

Year:  2000        PMID: 10996914     DOI: 10.1007/s001150050640

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  20 in total

Review 1.  Premotor Diagnosis of Parkinson's Disease.

Authors:  Heinz Reichmann
Journal:  Neurosci Bull       Date:  2017-08-03       Impact factor: 5.203

2.  Safety evaluation of nasopharyngeal cooling (RhinoChill®) in stroke patients: an observational study.

Authors:  Sven Poli; Jan Purrucker; Miriam Priglinger; Marek Sykora; Jennifer Diedler; André Rupp; Cem Bulut; Werner Hacke; Christian Hametner
Journal:  Neurocrit Care       Date:  2014-02       Impact factor: 3.210

3.  Selective hyposmia in Parkinson's disease?

Authors:  Antje Hähner; Wakunyambo Maboshe; Rute Baeta Baptista; Alexander Storch; Heinz Reichmann; Thomas Hummel
Journal:  J Neurol       Date:  2013-10-25       Impact factor: 4.849

4.  Odorant Item Specific Olfactory Identification Deficit May Differentiate Alzheimer Disease From Aging.

Authors:  Matthew R Woodward; Muhammad Ubaid Hafeez; Qianya Qi; Ahmed Riaz; Ralph H B Benedict; Li Yan; Kinga Szigeti
Journal:  Am J Geriatr Psychiatry       Date:  2018-04-19       Impact factor: 4.105

5.  Substantia nigra hyperechogenicity assessed by transcranial sonography is related to neuropsychological impairment in the elderly population.

Authors:  Inga Liepelt; Angela Wendt; Katherine J Schweitzer; Bjoern Wolf; Jana Godau; Alexandra Gaenslen; Theresa Bruessel; Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2008-03-27       Impact factor: 3.575

Review 6.  Taste in Parkinson's disease.

Authors:  Maria Paola Cecchini; Alfonso Fasano; Federico Boschi; Francesco Osculati; Michele Tinazzi
Journal:  J Neurol       Date:  2014-10-04       Impact factor: 4.849

7.  Olfactory Dysfunction in Parkinson's Disease Patients with the LRRK2 G2385R Variant.

Authors:  Ming Cao; Zhu-Qin Gu; Yuan Li; Hui Zhang; Xiao-Juan Dan; Shan-Shan Cen; Da-Wei Li; Piu Chan
Journal:  Neurosci Bull       Date:  2016-10-03       Impact factor: 5.203

8.  Olfactory dysfunction in Parkinson's disease: Benefits of quantitative odorant examination.

Authors:  Yuji Kawase; Kazuko Hasegawa; Noriko Kawashima; Emiko Horiuchi; Ken Ikeda
Journal:  Int J Gen Med       Date:  2010-07-21

Review 9.  [Olfactory dysfunction. Epidemiology, pathophsiological classification, diagnosis and therapy].

Authors:  G Förster; M Damm; H Gudziol; T Hummel; K-B Hüttenbrink; T Just; A Muttray; H Seeber; A Temmel; A Welge-Lüssen
Journal:  HNO       Date:  2004-08       Impact factor: 1.284

Review 10.  Olfactory loss as a supporting feature in the diagnosis of Parkinson's disease: a pragmatic approach.

Authors:  Katie Hoyles; Jagdish C Sharma
Journal:  J Neurol       Date:  2013-02-03       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.